N

Neomera BioLab

藥物研發平台

表现

RD 熱度指數

0
0100200300400500
項目排名: 12464/12942

RD 增長指數

--
0100200300400500
項目排名: --/12942

比較

關於Neomera BioLab

Neomera BioLab is a biotechnology company building a discovery platform for non-opioid chronic pain drugs, running wet-lab experiments and machine-learning models in one workflow for a field short of non-addictive analgesics. The obstacle it targets is that membrane-protein targets are hard to express stably, which makes highly selective candidates difficult to find through conventional screening.

Its lipid-vesicle expression system stabilises complex membrane proteins such as GPCRs and ion channels so previously undruggable targets can be screened, and binding data generated in-house then trains selectivity models that iterate candidate peptides, with initial programmes on state-independent sodium channel NaV1.8 and NaV1.9 inhibitors. The company is part of the Creative Destruction Lab advanced therapies cohort, which gives its experimental design and commercial path external review.

更新時間: 2026-10-30